Ten-Year Trends of Intravitreal Injection in South Korea Using the Health Insurance Review and Assessment Service Data
Korean Journal of Ophthalmology · 2025
DOI: 10.3341/kjo.2025.0023 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Korean Journal of Ophthalmology, 2025. Verfasst von Dong Woo Kim und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea. Hauptthemen laut MEDLINE: Angiogenesis Inhibitors, Insurance, Health, Intravitreal Injections. Die Arbeit nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Seoul National University Bundang Hospital.
Abstract (Originalsprache)
Purpose
This study aims to analyze the annual trends of intravitreal injection (IVI) in South Korea.
Methods
This retrospective study examined data from the Health Insurance Review and Assessment Service (HIRA)’s Health and Medical Big Data Open Portal. We investigated the number of patients who underwent IVIs and the total number of IVIs in Korea using the procedure code from 2014 to 2023, categorized by age group and type of healthcare facility. Patients aged under 40 years were excluded from the analysis. Additionally, trends in healthcare expenditures were analyzed.
Results
The number of patients undergoing IVI and the total number of IVI increased steadily, resulting in 92,124 patients (178.1 patients per 100,000 persons) and 291,784 injections in 2023, which contributed to an increase in medical expenses. The analysis of 10-year age intervals revealed that patients in their 70s were the most frequent recipients of IVI. The prevalence of IVI at primary healthcare facilities has been steadily increasing, from 20% in 2014 to 33% in 2023.
Conclusions
The patients receiving IVI and the total number of IVI have been steadily increasing, particularly in primary healthcare settings. Overall, medical expenses continue to rise. The findings of this study provide valuable evidence for the efficient allocation of medical resources in the future.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Ophthalmology, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea.
Förderung
- Seoul National University Bundang Hospital
Zitieren
APA
Kim, D. W., & Kim, M. S. (2025). Ten-Year Trends of Intravitreal Injection in South Korea Using the Health Insurance Review and Assessment Service Data. Korean Journal of Ophthalmology. https://doi.org/10.3341/kjo.2025.0023
Vancouver
Kim DW, Kim MS. Ten-Year Trends of Intravitreal Injection in South Korea Using the Health Insurance Review and Assessment Service Data. Korean Journal of Ophthalmology. 2025. doi:10.3341/kjo.2025.0023
BibTeX
@article{Kim2025,
author = {Kim, Dong Woo and Kim, Min Seok},
title = {Ten-Year Trends of Intravitreal Injection in South Korea Using the Health Insurance Review and Assessment Service Data},
journal = {Korean Journal of Ophthalmology},
year = {2025},
doi = {10.3341/kjo.2025.0023}
}
EUVIMED